MICHAEL NIZINSKI: Open Payments
NPI 1689453649 · WEATHERFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,868 in 56 payments from 15 companies in 2025. Trend: 2023 $199 · 2024 $2,193 · 2025 $1,868
Food & beverage: $1,674Education: $194
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 5 | $494 |
| Actelion Pharmaceuticals US, Inc. | 5 | $359 |
| Amgen Inc. | 18 | $272 |
| Novartis Pharmaceuticals Corporation | 12 | $245 |
| E.R. Squibb & Sons, L.L.C. | 2 | $132 |
| Inspire Medical Systems, Inc. | 1 | $65 |
| Boston Scientific Corporation | 1 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Alnylam Pharmaceuticals Inc. | 2 | $44 |
Products named: FFRct, REPATHA, LEQVIO, OPSUMIT, UPTRAVI, CAMZYOS, INSPIRE, APOLLO ESG System.
Industry payments across TX — which companies pay providers there.
